Centiva Capital, LP
Institutional investor · Portfolio as of Q3 2025
Top Holdings1,022 positions
ISHARES RUSSELL 2000 ETF | 4.5M | $1.1B | 10.3% | — | — | — | Increased — |
NVIDIA CORP | 3M | $555.1M | 5.3% | — | — | — | Increased — |
INVESCO QQQ TRUST SERIES 1 | 607,900 | $365M | 3.5% | — | — | — | Increased — |
TESLA INC | 746,100 | $331.8M | 3.2% | — | — | — | Increased — |
ALIBABA GROUP HOLDING LTD | 1.8M | $319.9M | 3.1% | — | — | — | Increased — |
ISHARES IBOXX HIGH YLD CORP | 3.7M | $300.4M | 2.9% | — | — | — | Decreased — |
ISHARES IBOXX HIGH YLD CORP | 3.5M | $282.1M | 2.7% | — | — | — | Increased — |
REGENERON PHARMACEUTICALS | 400,000 | $224.9M | 2.1% | — | — | — | Increased — |
PINDUODUO INC-ADR | 1.4M | $184.9M | 1.8% | — | — | — | Increased — |
MICROSOFT CORP | 355,900 | $184.3M | 1.8% | — | — | — | Increased — |
KRANESHARES CSI CHINA INTERN | 4.3M | $180.9M | 1.7% | — | — | — | New — |
FACEBOOK INC-CLASS A | 226,500 | $166.3M | 1.6% | — | — | — | Increased — |
SPDR S&P 500 ETF TRUST | 240,800 | $160.4M | 1.5% | — | — | — | Decreased — |
AMAZON.COM INC | 700,000 | $153.7M | 1.5% | — | — | — | Increased — |
ALIBABA GROUP HOLDING LTD | 845,600 | $151.1M | 1.4% | — | — | — | Increased — |
ELI LILLY & CO | 187,300 | $142.9M | 1.4% | — | — | — | New — |
APPLE INC | 530,000 | $135M | 1.3% | — | — | — | Increased — |
ADVANCED MICRO DEVICES | 817,500 | $132.3M | 1.3% | — | — | — | Increased — |
ISHARES TR | 1.2M | $128.7M | 1.2% | — | — | — | Decreased — |
ISHARES RUSSELL 2000 ETF | 508,100 | $122.9M | 1.2% | — | — | — | Decreased — |
Centiva Capital, LP manages $10.5B across 1022 positions as of Q3 2025. Top holdings: IWM puts (10.3%), NVDA puts (5.3%), QQQ puts (3.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 374 new positions, 912 exits, 109 increased. No standout high-conviction moves this quarter. Portfolio: $10.5B across 1022 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR